Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-261-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-03-08"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20110308.22.2-261-000"2
lpv:hasSubsequent	lp_eu:2011-03-08-Speech-2-262-0002
lpv:speaker	lp:Licia Ronzulli2
lpv:spokenAs	member; EMPL (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the countries of South Asia (2009-09-16--2014-06-30)3 member_of_the_bureau; EPP (2009-09-16--2014-06-30)3 substitute; ENVI (2009-09-29--2011-06-26)3 substitute; DROI (2009-07-16--2012-01-18)3 vice-chair; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-17--2014-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-05)3
lpv:translated text	"Even through the virulence of H1N1 influenza in Europe has not been particularly aggressive, this virus has so far caused no fewer than 4 700 deaths. The report published by the European Centre for Disease Prevention and Control (ECDC) notes that, in the management of the virus, the EU has been unable to adapt quickly to the medical measures necessary to limit infection. This is largely attributable to prevention strategies adopted in the various Member States, planned in consultation with the World Health Organisation (WHO) years ago without ever having received substantial updates. To prevent such situations recurring, in view of the harsh criticism received over the manner of distribution of vaccines, we must concentrate our efforts specifically in this direction in the future, optimising authorisation procedures for the marketing of medicinal products used when reacting to health crises."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph